REVISITING THE GLP1 CONTROVERSY, SHORTAGE AND SOLUTIONS FOR WEIGHT MANAGEMENT
In late 2024 I spoke with an academically trained cardiologist expert in cardiometabolic risk prevention and obesity medicine, educator, Dr. Eldad Einav, from Beverly Hills, CA about the ongoing controversy about the shortage and patient access to the exciting new weight loss treatments such as GLP1 agonists. He shared many practical, clinical insights and research that are important to revisit today for patients, physicians, and payers who are seeking to provide the best solutions and learn from some recent shortcomings.
0:00 Highlight #1 - Distinguishing the quality of weight loss solutions…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.